Givlaari (givosiran) safely led to a complete resolution of annual attacks in people with acute hepatic porphyria (AHP), according to…
Articles by Patricia Inácio, PhD
Heavy alcohol consumption and hereditary hemochromatosis, a genetic disorder characterized by iron overload, are the leading risk factors for porphyria…
Treatment with Givlaari (givosiran) successfully resolved acute attacks of acute intermittent porphyria (AIP) in a 36-year-old woman who…
Cosentyx (secukinumab) — a treatment approved for a skin condition called psoriasis — successfully treated both that disorder and porphyria…
A man in his 40s with a history of acute intermittent porphyria (AIP) had an attack triggered by a…
For the first time in Thailand, home to an estimated 350 undiagnosed acute intermittent porphyria (AIP) patients, molecular testing…
A report described a case of variegate porphyria, a type of acute porphyria, in a 9-year-old girl who had…
People with acute hepatic porphyria (AHP) having recurrent attacks are burdened with chronic symptoms between those attacks, according to data…
A total of 30 patient advocacy groups working to further understanding and the needs of people living with rare diseases…
A large proportion of people with acute intermittent porphyria (AIP) may still be undiagnosed in China, according to a recent…